These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15114254)

  • 21. Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge.
    Abelson MB; Spangler DL; Epstein AB; Mah FS; Crampton HJ
    Curr Eye Res; 2007 Dec; 32(12):1017-22. PubMed ID: 18085465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of topical cyclosporine a 0.05%, cyclosporine a 2%, epinastine hydrochloride 0.05%, and prednisolone acetate 1% on allergic inflammation in an experimental allergic conjunctivitis model.
    Semsettin B; Sinan E; Nigar V
    Cornea; 2013 Nov; 32(11):1465-9. PubMed ID: 24055903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In brief: OTC alcaftadine (Lastacaft Once Daily Relief) for allergic conjunctivitis.
    Med Lett Drugs Ther; 2022 May; 64(1650):78. PubMed ID: 35536123
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of tranilast ophthalmic solution on allergic conjunctivitis in guinea pigs].
    Itoh F; Komatsu Y; Taya F; Isaji M; Kojima M; Momose Y; Suzawa H; Miyata H; Shibazaki T
    Nihon Yakurigaku Zasshi; 1993 Jan; 101(1):27-32. PubMed ID: 7680329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of chamber scarification in the detection of allergic contact dermatitis to ophthalmic solutions.
    Okereke UR; Cohen DE
    Dermatitis; 2014; 25(6):373-4. PubMed ID: 25384224
    [No Abstract]   [Full Text] [Related]  

  • 26. Bepotastine (bepreve)--an ophthalmic H1-antihistamine.
    Med Lett Drugs Ther; 2010 Feb; 52(1331):11-2. PubMed ID: 20216525
    [No Abstract]   [Full Text] [Related]  

  • 27. [Opatanol].
    Johansen S
    Ugeskr Laeger; 2003 Jul; 165(30):2957. PubMed ID: 12926197
    [No Abstract]   [Full Text] [Related]  

  • 28. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
    Galatowicz G; Ajayi Y; Stern ME; Calder VL
    Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population.
    Abelson MB; Ferzola NJ; McWhirter CL; Crampton HJ
    Pediatr Allergy Immunol; 2004 Dec; 15(6):551-7. PubMed ID: 15610370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
    Abelson MB; Gomes PJ; Vogelson CT; Pasquine TA; Turner FD; Wells DT; Robertson SM
    Curr Med Res Opin; 2005 May; 21(5):683-91. PubMed ID: 15969867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of allergic conjunctivitis in children: the out-patients' department experience (allergic conjunctivitis in children: management and care).
    Napoli G; Allegri P; Musso C; Morchio AA; Callegarini L; Murialdo U; Tanca D; Marrè V
    Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):21-4. PubMed ID: 15745373
    [No Abstract]   [Full Text] [Related]  

  • 32. Relation between cooling sheet effect and tear histamine concenration in allergic conjunctivitis.
    Hirakawa N; Yanoshita R; Yoshii M; Yano H
    Yakugaku Zasshi; 2010 Jul; 130(7):971-5. PubMed ID: 20606377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of the dry eye and related problems.
    Barsam PC; Sampson WG; Feldman GL
    Ann Ophthalmol; 1972 Feb; 4(2):122-6 passim. PubMed ID: 4400490
    [No Abstract]   [Full Text] [Related]  

  • 34. [A systemic approach to the diagnosis and treatment of allergic conjunctivitis].
    Ndoye PA; Ba EA; Wane AM; Sow A; Ndiaye MR; Wade A
    Dakar Med; 2007; 52(1):13-6. PubMed ID: 19102085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitis.
    Fujishima H; Fukagawa K; Tanaka M; Uchio E; Takamura E; Nakagawa Y; Miyazaki D; Fukushima A; Okamoto S; Yokoi N
    Ophthalmologica; 2008; 222(4):232-9. PubMed ID: 18463425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allergic contact dermatitis of both eyes caused by alcaftadine 0.25%: a case report.
    Kim JH; Kim HJ; Kim SW
    BMC Ophthalmol; 2019 Jul; 19(1):158. PubMed ID: 31340775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Allergic conjunctivitis from cellular involvement to medical practice].
    Nicodin A
    Oftalmologia; 2007; 51(2):96-9. PubMed ID: 17937044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of histamine H(4) receptor in allergic conjunctivitis in mice.
    Nakano Y; Takahashi Y; Ono R; Kurata Y; Kagawa Y; Kamei C
    Eur J Pharmacol; 2009 Apr; 608(1-3):71-5. PubMed ID: 19249296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
    Abelson MB; Greiner JV
    Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of epinastine on chemokine production and MHC class II/CD54 expression in keratinocytes.
    Kobayashi M; Kabashima K; Tokura Y
    J Dermatol Sci; 2007 Feb; 45(2):144-6. PubMed ID: 17070018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.